VIA
CLB icon

Vantage Investment Advisors’s Core Laboratories CLB Stock Holding History

Vantage Investment Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-34
Closed -$4K – 845
2016
Q1 		$4K Hold
34
– – ﹤0.01% 640
2015
Q4 		$4K Hold
34
– – ﹤0.01% 630
2015
Q3 		$3K Hold
34
– – ﹤0.01% 671
2015
Q2 		$4K Sell
34
-34
-50% -$4.12K ﹤0.01% 624
2015
Q1 		$7K Buy
68
+34
+100% +$3.62K ﹤0.01% 652
2014
Q4 		$4K Hold
34
– – ﹤0.01% 631
2014
Q3 		$5K Buy
+34
New +$5.25K ﹤0.01% 568

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Vantage Investment Advisors's CLB Position: Q2 2016 in Review

Vantage Investment Advisors sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 34 shares — an estimated $4K sold.

Vantage Investment Advisors first reported a position in CLB in Q3 2014 and held it in 7 quarters. The position peaked at $7K in Q1 2015. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

  • Vantage Investment Advisors reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
  • Vantage Investment Advisors sold 34 Core Laboratories shares in Q2 2016, an estimated $4K.
  • Vantage Investment Advisors first reported a position in Core Laboratories in Q3 2014 and held it in 7 quarters.
  • Vantage Investment Advisors's Core Laboratories position peaked at $7K in Q1 2015.
  • 383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Vantage Investment Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.